Idenix Pharmaceuticals (IDIX)

[keitern]

Thanks, there seem to be a few areas where Tyzeka has a chance to become dominant within the HBV market. Pregnant women with HBV, HIV/HBV infected, etc. I suppose this is true for most competing drugs.